Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Total Liabilities (2020 - 2025)

Bio Essence has reported Total Liabilities over the past 6 years, most recently at $2.5 million for Q4 2025.

  • For Q4 2025, Total Liabilities fell 23.22% year-over-year to $2.5 million; the TTM value through Dec 2025 reached $2.5 million, down 23.22%, while the annual FY2025 figure was $2.5 million, 23.22% down from the prior year.
  • Total Liabilities for Q4 2025 was $2.5 million at Bio Essence, down from $3.3 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $5.0 million in Q1 2023 and troughed at $2.5 million in Q4 2025.
  • A 5-year average of $3.8 million and a median of $3.8 million in 2024 define the central range for Total Liabilities.
  • Biggest five-year swings in Total Liabilities: surged 190.15% in 2021 and later crashed 41.69% in 2023.
  • Year by year, Total Liabilities stood at $4.1 million in 2021, then rose by 15.94% to $4.8 million in 2022, then fell by 7.67% to $4.4 million in 2023, then dropped by 26.45% to $3.3 million in 2024, then fell by 23.22% to $2.5 million in 2025.
  • Business Quant data shows Total Liabilities for BIOE at $2.5 million in Q4 2025, $3.3 million in Q3 2025, and $3.2 million in Q2 2025.